Karen M. Marzlin – PESI – Cardiac Medications: Management of Complex Cardiovascular Disorders

Description

Karen M. Marzlin – PESI – Cardiac Medications: Management of Complex Cardiovascular Disorders download, Karen M. Marzlin – PESI – Cardiac Medications: Management of Complex Cardiovascular Disorders review, Karen M. Marzlin – PESI – Cardiac Medications: Management of Complex Cardiovascular Disorders free

Karen M. Marzlin – PESI – Cardiac Medications: Management of Complex Cardiovascular Disorders

Join Karen M. Marzlin, DNP, RN, CCNS, CCRN-CMC, CHFN, for an insightful and practical day focused on the common types of cardiac disorders that professionals like you see in your practice, and the medications currently used to treat them.

Drawing from three decades of experience treating cardiology patients, Karen will provide you with cutting-edge information regarding the selection of particular cardiac medications, the desired outcomes, potential side effects and drug interactions. Leave with a clear understanding of the physiological basis for cardiovascular drug therapy and drugs used to manipulate hemodynamic parameters, alter the cardiac electrical system, interrupt the clotting process, and to treat a variety of cardiovascular disease states.

Don’t miss this opportunity to keep pace with the ever-changing field of cardiac care, and through the information gained in this seminar, reduce the risk of potential adverse consequences for your patients. You will leave with a holistic perspective of cardiovascular pharmacology and its role in providing your patient with better outcomes and quality of life.

Speaker

Karen M. Marzlin, DNP, RN, CCNS, CCRN-CMC, CHFN
Acute Care Clinical Nurse Specialist/Co-Owner
Key Choice

Karen M. Marzlin, DNP, RN, CCNS, CCRN-CMC, CHFN, is an acute care Clinical Nurse Specialist practicing with medical cardiology patients in a 56-bed variable staffing CCU. Karen has been a nurse for over 26 years and has spent her entire career working with the cardiac patient. Karen also dedicated 10 years of her career to management and cardiovascular program administration. She has a passion for creating excellence at the bedside that is evident in her daily practice.

Karen, in addition to maintaining a part-time clinical practice, is a co-owner of Key Choice, a training and consulting business. She travels nationally and provides continuing education on a wide variety of cardiovascular and critical care topics as well as leadership/management consulting. Her presentations are enthusiastically delivered and offer practical tips that help everyone achieve excellence at the bedside. Linking knowledge to practice is the goal of every education program.

Karen collaborated on Cardiovascular Nursing Practice: A Comprehensive Nursing Resource Manual published by CNEA in 2007.

Speaker Disclosures:

Financial: Karen Marzlin receives a speaking honorarium from PESI, Inc.

Nonfinancial: Karen Marzlin has no relevant nonfinancial relationship to disclose.

Target Audience

Nurses, Pharmacists and Physician Assistants

Outline

Hemodynamics and Shock

• Physiological determinants of myocardial performance
• Vasodilators

• Vasopressors
• Inotropes
• Shock: Dopamine versus Norepinephrine
• Nuances of decompensated heart failure

Risk Factor Optimization

• Statin therapy in primary and secondary prevention
• Other Antilipid agents: when to use what?
• Outcome trials for lipid lowering agents

• AIM High
• Thrive

• Drug choices in hypertension
• Resistant hypertension

Atrial Fibrillation

• Antiarrhythmic pharmacology for rate control
• Antiarrhythmic pharmacology for rhythm control
• Clinical implications of potassium channel blockers
• Special considerations for Dronedarone and Amiodarone
• Anticoagulant medication options

• Fibrinolytics
• Anticoagulants
• Antiplatelets

Therapeutic Advances for Acute Coronary Syndrome

• Prasugrel
• Ticagrelor
• Epleranone post-STEMI
• Non-Steroidals
• ASA and CABG
• Contrast nephropathy

Heart Failure

• Optimal loop diuretic / dose and route of administration
• Nesiritide
• OPTIME Trial
• Serelaxin
• RAAS drugs
• Evidence-based beta blockers
• Drugs not to give for systolic dysfunction

Pulling it All Together: A Patient-Centered Approach to Pharmacology and Prescribing

Objectives

1. Justify the physiological basis for cardiovascular drugs used to support hemodynamics and optimize cardiac output.
2. Select options in the treatment of dyslipidemia and hypertension by contrasting the differences in lipid lowering agents and comparing the similarities in antihypertensive agents.
3. Communicate key evidence that guides decision-making regarding pharmacological choices in patients with atrial fibrillation.
4. Assess the pharmacology in the patient with acute coronary syndrome with short-term and long-term treatment goals.
5. Determine the role of pharmacological agents in interrupting abnormal neurohormonal responses in patients with heart failure.
6. Evaluate patient partnering as a method of optimizing medication effectiveness.

Frequently Asked Questions:

1. Innovative Business Model:
   • Embrace the reality of a genuine business! Our approach involves forming a group buy, where we collectively share the costs among members. Using these funds, we purchase sought-after courses from sale pages and make them accessible to individuals facing financial constraints. Despite potential reservations from the authors, our customers appreciate the affordability and accessibility we provide.
2. The Legal Landscape: Yes and No:
   • The legality of our operations falls into a gray area. While we lack explicit approval from the course authors for resale, there’s a technicality at play. When procuring the course, the author didn’t specify any restrictions on resale. This legal nuance presents both an opportunity for us and a boon for those seeking budget-friendly access.
3. Quality Assurance: Unveiling the Real Deal:
   • Delving into the heart of the matter – quality. Acquiring the course directly from the sale page ensures that all documents and materials are identical to those obtained through conventional means. However, our differentiator lies in going beyond personal study; we take an extra step by reselling. It’s important to note that we are not the official course providers, meaning certain premium services aren’t included in our package:
     • No coaching calls or scheduled sessions with the author.
     • No access to the author’s private Facebook group or web portal.
     • No entry to the author’s exclusive membership forum.
     • No direct email support from the author or their team.

   We operate independently, aiming to bridge the affordability gap without the additional services offered by official course channels. Your understanding of our unique approach is greatly appreciated.

Refund is acceptable:

• Firstly, item is not as explained
• Secondly, Item do not work the way it should.
• Thirdly, and most importantly, support extension can not be used.

Thank you for choosing us! We’re so happy that you feel comfortable enough with us to forward your business here.